Mapping large numbers of results may take a few moments.
Search Results
Showing 151 - 200 of 328 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company IMMvention Therapeutix Inc. | Activity: Research and Development | Company Description IMMvention develops small molecule therapies that inhibit multiple inflammasome receptors to treat both rare and prevalent inflammatory diseases. | Location Research Triangle Park |
| |
Company Imugene Limited (Durham) | Activity: Research and Development | Company Description Imugene is a clinical stage immuno-oncology company developing treatments that seek to activate the immune system of cancer patients to identify and eradicate tumors. | Location Durham |
| |
Company Inceptor Bio LLC | Activity: Research and Development | Company Description Inceptor Bio develops next-generation cell therapy platforms, across multiple cell types, to cure cancers. Its site includes a manufacturing facility for production of its therapies. | Location Raleigh |
| |
Company Incyclix Bio LLC | Activity: Research and Development | Company Description Incyclix Bio is developing novel cancer treatments through the selective inhibition of specific CDK (cyclin-dependent kinase) family members to address unmet medical needs of oncology patients. | Location Research Triangle Park |
| |
Company Inhalon Biopharma Inc. | Activity: Research and Development | Company Description Inhalon Biopharma is a clinical-stage, inhaled immunotherapy company developing prophylactic and therapeutic antibodies (mAb) for acute respiratory infections. Inhalon has a patented proprietary muco-trapped mAb platform technology with broad IP coverage of inhaled mAb delivery. | Location Morrisville |
| |
Company Insoma Bio Inc. | Activity: Research and Development | Company Description InSomaBio is developing recombinant, protein-based materials to solve problems in tissue engineering and regenerative medicine. | Location Durham |
| |
Company Invitrox Inc. | Activity: Contract Research and Testing | Company Description Invitrox provides GLP-compliant bioanalytical services for nonclinical and clinical drug development studies, with expertise in method development and validation, small and large molecules, sample analysis, metabolites, biomarkers and drug monitoring. | Location Research Triangle Park |
| |
Company Irex Pharma LLC | Activity: Research and Development | Company Description Irex Pharma is an early-stage drug discovery company focused on identifying and commercializing novel therapeutics to control excess mucus in pulmonary patients. | Location Chapel Hill |
| |
Company Ironshore Pharmaceuticals Inc. | Activity: Sales and Operations | Company Description Ironshore Pharmaceuticals develops, commercializes and distributes novel pharmaceuticals, including a novel oral treatment for ADHD with delayed-release properties. | Location Morrisville |
| |
Company Istari Oncology Inc. | Activity: Research and Development | Company Description ISTARI Oncology is developing immunotherapies for cancer treatment. | Location Morrisville |
| |
Company Jaguar Gene Therapy LLC (Analytical Development) | Activity: Research and Development | Company Description Jaguar Gene Therapy develops gene therapies for patients suffering from severe genetic diseases. The company's analytical development lab is located in Durham. | Location Durham |
| |
Company Jaguar Gene Therapy LLC (Process Sciences Lab) | Activity: Research and Development | Company Description Jaguar Gene Therapy develops gene therapies for patients suffering from severe genetic diseases. The company's process sciences lab is located in Cary. | Location Cary |
| |
Company Jericho Sciences LLC | Activity: Research and Development | Company Description Jericho Sciences is developing antiviral therapeutics and corresponding personalized diagnostic assays which specifically address the limitations of current combination antiretroviral therapy (cART) in the clinical management of HIV-1 infection to reduce underlying sources of persistent virus. | Location Durham |
| |
Company Jurata Thin Film Inc. | Activity: Research and Development | Company Description Jurata Thin Film is developing an oral, thin film vaccine delivery method that preserves live viruses, bacteria, antibodies and enzymes inexpensively, without refrigeration. | Location Chapel Hill |
| |
Company Kaio Therapy LLC | Activity: Research and Development | Company Description KAIO Therapy develops an immunotherapy technology to treat solid tumors. | Location Raleigh |
| |
Company Karamedica Inc. | Activity: Research and Development | Company Description Karamedica has developed a plasma treatment of batch quantities of chitosan and other biopolymers in order to lower endotoxin levels. Karamedica is also currently developing a nanoparticle therapy for cerebral amyloid angiopathy. | Location Raleigh |
| |
Company Kartha Pharmaceuticals Inc. | Activity: Research and Development | Company Description Kartha Pharmaceuticals develops and commercializes pharmaceutical products. | Location Matthews |
| |
Company KBI Biopharma Inc. (Corporate HQ) | Activity: Production and Manufacturing | Company Description KBI Biopharma, a JSR Life Sciences Company, offers contract development and biopharmaceutical manufacturing services such as formulation, analytical method development, stability services, process development and recombinant protein API manufacturing. | Location Durham |
| |
Company KBI Biopharma Inc. (Patriot Park Facility) | Activity: Production and Manufacturing | Company Description KBI Biopharma, a JSR Life Sciences Company, offers contract development and biopharmaceutical manufacturing services such as formulation, analytical method development, stability services, process development and recombinant protein API manufacturing. The Patriot Park Facility is a 150,000 square-foot cGMP biologics manufacturing facility. | Location Durham |
| |
Company KBI Biopharma Inc. (Venture Center Facility) | Activity: Production and Manufacturing | Company Description KBI Biopharma, a JSR Life Sciences Company, offers contract development and biopharmaceutical manufacturing services. KBI's Venture Center Facility conducts process and analytical development, process characterization and cell line development. | Location Durham |
| |
Company KeraNetics LLC | Activity: Research and Development | Company Description KeraNetics develops keratin-based biomaterials to be used for wound care and tissue regeneration. | Location Winston-Salem |
| |
Company Kowa Research Institute Inc. | Activity: Research and Development | Company Description Kowa Research Institute, a division of Kowa Company Ltd., develops therapeutic drugs for the treatment of cardio-metabolic diseases such as diabetes and atherosclerosis, pain and sensory organ disorders. | Location Morrisville |
| |
Company Krenitsky Pharmaceuticals Inc. | Activity: Research and Development | Company Description Krenitsky Pharmaceuticals discovers and develops drug candidates, with a focus on disorders of the nervous system. | Location Chapel Hill |
| |
Company KriGen Pharmaceuticals LLC | Activity: Production and Manufacturing | Company Description KriGen Pharmaceuticals develops pharmaceutical products, and provides finished product formulation solutions and sterile active pharmaceutical ingredients to generic and branded pharmaceutical companies. | Location Lillington |
| |
Company Kriya Therapeutics Inc. | Activity: Production and Manufacturing | Company Description Kriya Therapeutics develops AAV-based gene therapies for the treatment of type 1 and type 2 diabetes, severe obesity, thyroid eye disease (TED) and other indications. This location is the company's internal manufacturing facility. | Location Morrisville |
| |
Company LadeRx LLC | Activity: Research and Development | Company Description LadeRx is developing new technology for diagnostic radiology. | Location Durham |
| |
Company Lamassu Pharma Inc. | Activity: Research and Development | Company Description Lamassu Pharma is developing small molecule therapeutics to treat acute pancreatitis. | Location Durham |
| |
Company Life Edit Therapeutics | Activity: Research and Development | Company Description Life Edit Therapeutics, an ElevateBio company, identifies novel genome editing systems from a database of microbial genomes. These systems are then developed for use as human therapeutics, both in-house and through external partnerships. | Location Research Triangle Park |
| |
Company LifeNet Health | Activity: Research and Development | Company Description LifeNet Health provides transplant solutions, including cellular therapy research, organ procurement and bio-implant. The North Carolina facility isolates liver cells and adult stem cells for applications in drug discovery and toxicity testing. | Location Research Triangle Park |
| |
Company Lindy Biosciences Inc. | Activity: Research and Development | Company Description Lindy Biosciences develops protein therapeutic formulations for non-standard formulations such as suspension formulations (for high-concentration delivery of antibodies), encapsulation (for sustained/controlled release) or dry powder pulmonary delivery. | Location Morrisville |
| |
Company Liquidia Corporation | Activity: Research and Development | Company Description Liquidia Corporation develops and commercializes human therapeutics for the treatment of pulmonary arterial hypertension (PAH) and other applications using its proprietary particle engineering technology. | Location Morrisville |
| |
Company Locus Biosciences Inc. | Activity: Research and Development | Company Description Locus Biosciences is developing CRISPR-engineered bacteriophage (“crPhage”) products that kill target bacteria by irreversibly destroying their DNA while leaving the many species of beneficial bacteria in the body unharmed. | Location Morrisville |
| |
Company MAA Laboratories Inc. | Activity: Research and Development | Company Description MAA Laboratories develops new drug products by nanoformulating currently marketed drugs with meaningful clinical benefits. The company’s NanoCont technology requires small clinical trials for the new product regulatory approval through 505(b)(2) pathway. | Location Durham |
| |
Company Madera Therapeutics LLC | Activity: Research and Development | Company Description Madera Therapeutics is developing small molecule anti-cancer agents that function via activation of the mitochondrial protease, ClpP. Madera's TR Compounds have direct effects on bulk cancer cells and inhibit cancer stem cell function. | Location Cary |
| |
Company Mallinckrodt Pharmaceuticals | Activity: Production and Manufacturing | Company Description Mallinckrodt manufactures acetaminophen, the active ingredient in Tylenol, at its pharmaceutical facility in Raleigh. | Location Raleigh |
| |
Company Marius Pharmaceuticals LLC | Activity: Research and Development | Company Description Marius Pharmaceuticals develops therapeutic treatments, with a focus on oral testosterone replacement therapies for adult men symptomatic of hypogonadism. | Location Raleigh |
| |
Company Mastezellen Bio Inc. | Activity: Research and Development | Company Description Mastezellen Bio is developing therapeutics for the treatment of diseases and disorders with mast cell involvement. | Location Research Triangle Park |
| |
Company Mayne Pharma USA | Activity: Sales and Operations | Company Description Mayne Pharma manufactures oral and topical dosage branded and generic pharmaceuticals. Mayne Pharma also provides contract development and manufacturing services. Mayne Pharma's U.S. headquarters is in Raleigh. | Location Raleigh |
| |
Company MD Scientific LLC | Activity: Research and Development | Company Description MD Scientific developed the EndoTool Glucose Management System and is currently developing a drug to prevent kidney and heart injury from iodinated contrast agents. | Location Charlotte |
| |
Company MedKoo Biosciences Inc. | Activity: Sales and Operations | Company Description MedKoo Biosciences supplies biochemical reagents, specializing in small molecule research-used medicines (i.e. non-human-use drugs). | Location Morrisville |
| |
Company MedPharm (Durham) | Activity: Contract Research and Testing | Company Description MedPharm is a CDMO that provides topical and transdermal product design, development, and manufacturing services. | Location Durham |
| |
Company MedPharm (Morrisville) | Activity: Production and Manufacturing | Company Description MedPharm is a CDMO that provides topical and transdermal product design, development, and manufacturing services. | Location Morrisville |
| |
Company Merakris Therapeutics Inc. | Activity: Research and Development | Company Description Merakris Therapeutics develops biotherapeutic technologies derived from stem cells that promote homeostasis in damaged tissue. | Location Research Triangle Park |
| |
Company Merck & Co. Inc. (Durham) | Activity: Production and Manufacturing | Company Description Merck manufactures vaccine products at its Durham facility. | Location Durham |
| |
Company Merck & Co. Inc. (Wilson) | Activity: Production and Manufacturing | Company Description Merck's Wilson facility produces patented prescription products and performs granulation and tableting operations. | Location Wilson |
| |
Company Merlon Inc. | Activity: Research and Development | Company Description Merlon develops small-molecule inhibitors for treatment of BRAF-mutated cancers resistant to BRAF and MEK inhibitors. | Location Durham |
| |
Company Merz Aesthetics | Activity: Research and Development | Company Description Merz Aesthetics develops injectables, devices and skincare products. | Location Raleigh |
| |
Company Merz Therapeutics | Activity: Research and Development | Company Description Merz Therapeutics develops and commercializes neurological therapeutic treatment solutions for patients who suffer from movement disorders and neurological health conditions. | Location Raleigh |
| |
Company Midnight Pharma LLC | Activity: Research and Development | Company Description Midnight Pharma is developing a treatment for insomnia. | Location Morrisville |
| |
Company Milestone Pharmaceuticals USA Inc. | Activity: Research and Development | Company Description Milestone Pharmaceuticals is developing an investigational new drug intended to provide rapid-onset and short-acting treatment of paroxysmal supraventricular tachycardia (PSVT) episodes and other episodic conditions. | Location Charlotte |